![DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA LLC]](https://medic.hrt.org//dailymed/images/87ed8125-8402-5d53-e053-2995a90a6516/-2 end.jpg)
![DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA LLC]](https://medic.hrt.org//dailymed/images/87ed8125-8402-5d53-e053-2995a90a6516/1065-2 front.jpg)
![DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA LLC]](https://medic.hrt.org//dailymed/images/87ed8125-8402-5d53-e053-2995a90a6516/1065-2 middle.jpg)
- Directions for use
- Sincerus Florida, LLC adverse reactions.
- Active, inactive
- NDC 72934-1065-2 DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL 30 gm
-
INGREDIENTS AND APPEARANCE
DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025%
dapsone 8.5% / niacinamide 2% / tretinoin 0.025% gelProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-1065 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE 8.5 g in 100 g TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN 0.025 g in 100 g NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 2 g in 100 g Product Characteristics Color yellow Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-1065-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/03/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/03/2019 Labeler - Sincerus Florida LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida LLC 080105003 manufacture(72934-1065)
